Biomarkers and neurobiology of schizophrenia Peter FalkaiHans-Jürgen Möller Editorial Open access 29 June 2012 Pages: 363 - 364
Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis Stefan BusseHans-Gert BernsteinJohann Steiner Original Paper 14 December 2011 Pages: 365 - 374
Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand? Nenad VasicBernhard J. ConnemannJohannes Brettschneider Original Paper 16 December 2011 Pages: 375 - 391
Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6 Daniela L. KrauseJenny K. WagnerNorbert Müller Original Paper 21 January 2012 Pages: 393 - 401
Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency Arne NagelsAndré Kirner-VeselinovicSören Krach Original Paper 22 December 2011 Pages: 403 - 414
Abnormal bihemispheric responses in schizophrenia patients following cathodal transcranial direct stimulation Alkomiet HasanRichard AborowaThomas Wobrock Original Paper Open access 09 February 2012 Pages: 415 - 423
Response rate of catatonia to electroconvulsive therapy and its clinical correlates Dhanya RaveendranathanJanardhanan C. NarayanaswamySenthil V. Reddi Original Paper 30 December 2011 Pages: 425 - 430
Efficacy of bifocal diagnosis-independent group psychoeducation in severe psychiatric disorders: results from a randomized controlled trial K. RabovskyM. TrombiniG. Stoppe Original Paper 31 January 2012 Pages: 431 - 440
Ethics of clinical research with mentally ill persons Hanfried Helmchen Original Paper 03 January 2012 Pages: 441 - 452
Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients Julian A. J. JarosDaniel Martins-de-SouzaSabine Bahn Letter to the Editor 15 December 2011 Pages: 453 - 455
